ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA‐associated vasculitis

Abstract

There is no rationale for serial measurements of ANCA in AASV. For changes of therapy, the ANCA parameters should only be used in conjunction with clinical information.